MAP1LC3A Antikörper (N-Term)
Kurzübersicht für MAP1LC3A Antikörper (N-Term) (ABIN6656617)
Target
Alle MAP1LC3A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Hersteller Produkt- Nr.
- 200-401-h57
-
Hersteller
- Rockland
-
Verwendungszweck
- ATG8 Antibody
-
Kreuzreaktivität (Details)
- A BLAST analysis was used to suggest cross-reactivity with Anti-ATG8 from Opossum and rat based on 100 % homology with the immunizing sequence.
-
Aufreinigung
- Anti-ATG8 Antibody was purified by Protein G chromatography.
-
Immunogen
- ATG8 Antibody was produced from whole rabbit serum prepared by repeated immunizations with at the n-terminus portion of human ATG8.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry_Dilution: 5-10 μg/mL
Western_Blot_Dilution: 0.25-1 μg/mL
-
Kommentare
-
Suggested Applications: IF
Anti-ATG8 antibody is tested by IHC-P and WB. Expect a band approximately 16 kDa on specific lysates. Specific conditions for reactivity should be optimized by the end user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Stabilizer: 0.05 % BSA
Preservative: 0.05 % (w/v) Sodium Azide -
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.
-
Haltbarkeit
- 12 months
-
-
-
: "Biallelic DMXL2 mutations impair autophagy and cause Ohtahara syndrome with progressive course." in: Brain : a journal of neurology, Vol. 142, Issue 12, pp. 3876-3891, (2020) (PubMed).
-
: "Biallelic DMXL2 mutations impair autophagy and cause Ohtahara syndrome with progressive course." in: Brain : a journal of neurology, Vol. 142, Issue 12, pp. 3876-3891, (2020) (PubMed).
-
- MAP1LC3A (Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
-
Andere Bezeichnung
- MAP1LC3A
-
Hintergrund
-
Synonyms: Activating transcription factor 8
Background: Anti-ATG8 antibody detects human ATG8. MAP1A and MAP1B are microtubule-associated proteins made up of a heavy chain and multiple light chain components. One such light chain component associated with these proteins is ATG8. ATG8 (also called MAP1LC3A and APG8), an ~16KDa mammalian homolog of yeast Atg8, is a cytoplasmic protein that plays an essential role in the process and regulation of autophagy. ATG8 is an evolutionarily conserved protein that belongs to LC3 family. ATG8 interacts with various proteins in the cytoplasm including mammalian homologues of Atg4, Atg7, Atg3 and Atg12 and gets modified into LC3-I and LC3-II respectively. Both of these forms are suggested to be involved in the formation and intracellular trafficking of autophagosomes in mammalian cells. Anti-ATG8 antibody are ideal for investigators invovled in apoptosis research.
Gene Name: MAP1LC3A
-
Gen-ID
- 84557
-
NCBI Accession
- NP_115903
-
UniProt
- Q9H492
-
Pathways
- Autophagie
Target
-